Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.

[1]  J. Mellors,et al.  HIV-1 remission and possible cure in a woman after haplo-cord blood transplant , 2023, Cell.

[2]  T. Luedde,et al.  In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation , 2023, Nature Medicine.

[3]  J. Martinez-Picado,et al.  Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells , 2022, Viruses.

[4]  Leanne S. Whitmore,et al.  Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species. , 2022, Cell host & microbe.

[5]  M. Axthelm,et al.  Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis , 2022, PloS one.

[6]  S. Hansen,et al.  Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species , 2022, PLoS pathogens.

[7]  A. Sylwester,et al.  CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab , 2021, Frontiers in Immunology.

[8]  N. Haigwood,et al.  Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission , 2021, Nature Communications.

[9]  R. Krance,et al.  Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant. , 2020, Blood.

[10]  Tonya Swanson,et al.  Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection , 2020, Journal of clinical apheresis.

[11]  N. Kröger,et al.  Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1 , 2020, Science Translational Medicine.

[12]  J. Martinez-Picado,et al.  Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report , 2020, The lancet. HIV.

[13]  J. Safrit,et al.  The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques , 2020, PLoS pathogens.

[14]  Eisa Mahyari,et al.  Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications , 2020, Xenotransplantation.

[15]  R. Siliciano,et al.  The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. , 2019, Cell host & microbe.

[16]  J. Martinez-Picado,et al.  HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation , 2019, Nature.

[17]  R. Siliciano,et al.  A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.

[18]  M. Robb,et al.  Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy , 2018, Nature Communications.

[19]  S. Furlan,et al.  Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation , 2018, Nature Communications.

[20]  B. Clotet,et al.  Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant , 2018, Annals of Internal Medicine.

[21]  L. Picker,et al.  Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound , 2018, Nature Medicine.

[22]  M. Kamata,et al.  Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS , 2017, PLoS pathogens.

[23]  Charles R. Thomas,et al.  Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes , 2017, Nature Communications.

[24]  D. Richman,et al.  Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study , 2017, PLoS medicine.

[25]  F. Plummer,et al.  Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection , 2017, Journal of medical primatology.

[26]  Todd M. Allen,et al.  Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque. , 2017, AIDS Research and Human Retroviruses.

[27]  S. Lewin,et al.  Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals , 2017, Journal of acquired immune deficiency syndromes.

[28]  N. Klatt,et al.  Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques , 2017, Journal of visualized experiments : JoVE.

[29]  J. Schiffer,et al.  Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia , 2017, Journal of Virology.

[30]  Daniel I. S. Rosenbloom,et al.  Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics , 2017, The Journal of experimental medicine.

[31]  R. Sékaly,et al.  Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation. , 2017, JCI insight.

[32]  D. Fuller,et al.  Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques , 2016, PloS one.

[33]  R. Siliciano,et al.  HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.

[34]  D. O’Connor,et al.  Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer , 2015, Journal of Virology.

[35]  N. Kröger,et al.  Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  K. MacDonald,et al.  A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy. , 2015, Vaccine.

[37]  A. Haase,et al.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.

[38]  Emily B Hanhauser,et al.  Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.

[39]  G. Silvestri,et al.  Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant , 2014, PLoS pathogens.

[40]  Jinyan Liu,et al.  Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.

[41]  J. Mellors,et al.  Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy , 2014, PloS one.

[42]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[43]  A. Krishnan,et al.  Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma , 2013, Journal of acquired immune deficiency syndromes.

[44]  A. LaCasce,et al.  Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. , 2013, The Journal of infectious diseases.

[45]  Melisa L. Budde,et al.  Adoptive Transfer of Lymphocytes Isolated from Simian Immunodeficiency Virus SIVmac239Δnef-Vaccinated Macaques Does Not Affect Acute-Phase Viral Loads but May Reduce Chronic-Phase Viral Loads in Major Histocompatibility Complex-Matched Recipients , 2013, Journal of Virology.

[46]  J. Hoxie,et al.  Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. , 2012, The New England journal of medicine.

[47]  Melisa L. Budde,et al.  Specific CD8+ T Cell Responses Correlate with Control of Simian Immunodeficiency Virus Replication in Mauritian Cynomolgus Macaques , 2012, Journal of Virology.

[48]  E. Thiel,et al.  Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. , 2011, Blood.

[49]  E. Elder,et al.  GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression. , 2010, Blood.

[50]  Melisa L. Budde,et al.  Characterization of Mauritian cynomolgus macaque major histocompatibility complex class I haplotypes by high-resolution pyrosequencing , 2010, Immunogenetics.

[51]  R. Talamini,et al.  Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  Melisa L. Budde,et al.  Extralymphoid CD8+ T Cells Resident in Tissue from Simian Immunodeficiency Virus SIVmac239Δnef-Vaccinated Macaques Suppress SIVmac239 Replication Ex Vivo , 2010, Journal of Virology.

[53]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[54]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[55]  L. Picker,et al.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, Journal of Experimental Medicine.

[56]  R. Siliciano,et al.  A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy , 2009, Journal of Virology.

[57]  Jennifer J. Lhost,et al.  Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells , 2009, Journal of Virology.

[58]  D. Burton,et al.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.

[59]  M. Muñoz-Fernández,et al.  Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected? , 2007, AIDS research and human retroviruses.

[60]  A. Hughes,et al.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques , 2007, Immunogenetics.

[61]  D. Watkins,et al.  Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.

[62]  D. O’Connor,et al.  Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.

[63]  J. Mascola,et al.  Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.

[64]  Matthew C Strain,et al.  Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.

[65]  R. Siliciano,et al.  Resting CD4+ T Lymphocytes but Not Thymocytes Provide a Latent Viral Reservoir in a Simian Immunodeficiency Virus-Macaca nemestrina Model of Human Immunodeficiency Virus Type 1-Infected Patients on Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[66]  R. Lempicki,et al.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Schmitz,et al.  A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. , 1999, The American journal of pathology.

[68]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[69]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[70]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[71]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[72]  R. Sussman,et al.  Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect. , 1995, American journal of physical anthropology.

[73]  L. Picker,et al.  In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses , 2019, Journal of Virology.

[74]  S. Pavletic,et al.  Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[75]  V. Calvez,et al.  High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. , 2004, Haematologica.